WAGO 2026 Poster Presentations

Presenting Author: Patrick Penalosa, MD, Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of California, San Diego

Poster #9

Recurrent cervical carcinoma in the era of antibody-drug conjugates (ADCs): Is sustained, durable remission achievable?

Presenting Author: Jenna Reppas, BS, University of California, Irvine

Poster #10

Treatment Shift from Primary Surgery to Radiotherapy for Stage T1b Cervical Cancer in the United States

Presenting Author: Jane O’Bryan, MD MPH, Los Angeles General Medical Center/University of Southern California – Keck

Poster #11

Home HPV Self-Collection in Bone Marrow Transplant Patients: A Feasibility Study

Presenting Author: Katherine M. Bolten, MD, Oregon Health and Science University

Poster #12

Comparative evaluation of artificial intelligence-generated responses to patient questions on HPV and cervical cancer

Presenting Author: Emma Barr, MD, Adventist Health White Memorial

Poster #13

Oncofertility referrals and obstetric outcomes in women with rare ovarian malignancies.

Presenting Author: Alexander Frumovitz, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center

Poster #14

Improving Timely Adjuvant Chemotherapy After Cytoreductive Surgery for Ovarian Cancer: Evaluation of an SGO Quality Indicator in a Rural Academic–Community Setting

Presenting Author: Austin M. Garcia, MD, UCSF Fresno Obstetrics and Gynecology

Poster #15

BMI1 Mediation of Chemoresistance through DNA Damage Repair Mechanisms in a Patient-Derived Ovarian Cancer Cell Line

Presenting Author: Ethan Nyein, MD, Loma Linda University

Poster #16

Endometrial Cancer Disparities in South Texas-Bexar County: Hysterectomy-Adjusted Incidence in Young Hispanic Women

Presenting Author: Ashlyn Parkhurst, MD, University of Texas Health Science Center at San Antonio

Poster #17

Fertility Preservation after Endometrial Cancer Diagnoses: Outcomes from a Tertiary Referral Center

Presenting Author: Odera O. Okafor, MD, MPP, University of California San Francisco

Poster #18

Impact of BMI: A comparison of national versus institutional surgical outcomes among patients with endometrial cancer

Presenting Author: Ananya G. Reddy, MPH, Washington University in St. Louis School of Medicine

Poster #19

Uterine Carcinosarcoma with Mixed or Pure Sarcomatous Metastasis: A Case Series

Presenting Author: Siena M. Shepherd, MD, University of Texas Health Science Center at San Antonio

Poster #20

Molecular Pathway Analysis of NSMP Endometrial Cancers Reveals Distinct Subtypes

Presenting Author: Vignesh Ramchandran, MD, UCLA

Poster #21

Too much pressure? The impact of pre-operative hysteroscopy on positive pelvic washings in high grade uterine cancer

Presenting Author: Austin M. Garcia, MD, UCSF Fresno Obstetrics and Gynecology

Poster #22

Influence of JAK1 pathogenic variant zygosity on tumor immune microenvironment and survival in endometrial cancer

Presenting Author: Jayla Mondy, Resident, Vanderbilt University Medical Center

Poster #23

Identifying Non-Responders Early: Blood-Based Markers of Resistance in Endometrial Cancer to Atezolizumab and Bevacizumab

Presenting Author: Wanda Gan, MD, Helen Diller Family Comprehensive Cancer Center, UCSF

Poster #24

Modeling Personalized Radiotherapy in Endometrial Cancer: Genomic Associated Radiation Dose (GARD) Across Molecular Subtypes

Presenting Author: Catherine Kim, DO, Cleveland Clinic

Poster #25

An immune gene signature identifies an immune-responsive subset within copy number high endometrial cancer

Presenting Author: Halle Goodwin, MD, Atrium Health Levine Cancer

Poster #26

A cohort study assessing the utilization trend of glucagon-like peptide-1 receptor agonist on patients diagnosed with endometrial intraepithelial neoplasia and low-grade endometrial cancer

Presenting Author: Rohan Luhar, MD, MS, LAG Medical Center / Keck Hospital

Poster #27

Levonorgestrel intrauterine device treatment for endometrial intraepithelial neoplasia or endometrial cancer: comparison of patients declining definitive surgery and medically inoperable patients

Presenting Author: Megan Marshalla, MD, University of Oklahoma Stephenson Cancer Center

Poster #28

HER2 expression does not influence survival in patients with stage I uterine serous carcinoma, a multi-institutional study.

Presenting Author: Lucas Li, Cedars-Sinai

Poster #29

Socioeconomic barriers to timely initiation of treatment in patients with advanced cervical cancer diagnosed at a tertiary care center

Presenting Author: Michael Shu, MD , Rutgers Cancer Institute of New Jersey

Poster #30

Perspectives on oncofertility care from providers and adolescent & young adult cancer survivors in a frontier state

Presenting Author: Elizabeth Connelly, MD, University of New Mexico

Poster #31

Global Disparities Exist in Molecular and Somatic Genetic Testing for Gynecologic Cancers

Presenting Author: Brad Nakamura, MD , City of Hope

Poster #32

Challenges in evaluating rural disparities in endometriosis and endometriosis-associated ovarian carcinoma

Presenting Author: Julia Dexter, MD, University of Colorado

Poster #33

Practice Patterns for Patients Diagnosed with Gynecologic Cancer and Co-existing Intellectual/Developmental Disabilities

Presenting Author: Katherine Jane Chua, MD, University of California Davis Health System

Poster #34

Primacy of geography-based social determinants of health among barriers to outpatient specialty palliative care referrals for patients with gynecologic cancers.

Presenting Author: Hannah Nettelblad, MD, University of Kansas

Poster #35

Geographic Differences in Circulating Tumor DNA (ctDNA) Testing and Use in Gynecologic Cancers

Presenting Author: Brad Nakamura, MD, City of Hopec

Poster #36

Paclitaxel and anti-emetic hypersensitivity reaction rates in gynecologic oncology patients: a quality improvement project

Presenting Author: Riley Miller, Temple University Lewis Katz School of Medicine

Poster #37

Assessment of the LACE+ score as a predictor of 30-day readmission in gynecologic oncology patients

Presenting Author: Lauren Falk, University of Oklahoma Stephenson Cancer Center

Poster #38

Assessing Patient Satisfaction with Same-Day Discharge and Pain Management Following Robotic Gynecologic Oncology Surgery

Presenting Author: Kelli Lopes, UCSD School of Medicine

Poster #39

Prospective Evaluation of the Da Vinci Single-Port (SP) Robotic System for Gynecologic and Gynecologic Oncology Procedures

Presenting Author: Vinita Popat, MD, City of Hope National Medical Center

Poster #40

Vascular stapler versus traditional ligation in mitigating hemorrhage risk during cesarean hysterectomy

Presenting Author: Leah Ginn, DO, Medical College of Georgia (Augusta University)

Poster #41

Association of tobacco-smoking cessation and cancer stage in gynecologic malignancy.

Presenting Author: Jennifer Yao, Medical Student, USC Keck School of Medicine

Poster #42

A Society-wide Survey of Circulating Tumor DNA Integration in Gynecologic Cancer Care

Presenting Author: Rohan Luhar, MD, MS, University of Southern California + LA General Medical Center

Poster #43

Evaluation of circulating tumor DNA using the Haystack MRD assay in recurrent ovarian cancer: a tale of four patients

Presenting Author: Vinita Popat, MD, City of Hope National Medical Center

Poster #44

Real-world efficacy and practice patterns of mirvetuximab soravtansine in ovarian cancer

Presenting Author: Ravali Reddy, MD, The University of Texas MD Anderson Cancer Center

Poster #45

Impact of English language proficiency on upfront treatment selection and disease-specific survival in patients with epithelial ovarian cancer

Presenting Author: Moeko Suzuki, BS, University of California, Irvine School of Medicine

Poster #46

Real-world outcomes of sequential antibody-drug conjugate therapy in advanced gynecologic cancers: a single-institution experience

Presenting Author: Isabelle Chandler, Medical Student, David Geffen School of Medicine

Poster #47

Predicting complete interval cytoreduction (ICS) in advanced serous ovarian cancer (SOC) patients using CA-125 elimination rate constant K (KELIM): a single institution retrospective study

Presenting Author: Qi Zhang, MD, MS, Atrium Levine Cancer Institute

Poster #48

Demographic and Clinical Associations with WNT4 rs3820282 Genotype in Gynecologic Malignancies

Presenting Author: Stephanie Wang, MD , University of Colorado

Poster #49

Minimally invasive approach to hyperthermic intraperitoneal chemotherapy at the time of interval debulking surgery in patients with ovarian cancer

Presenting Author: Khrystyna Levytska, MD, Kaiser Permanente Los Angeles Medical Center

Poster #50

Exploratory analysis of patient-reported outcomes in individuals with newly diagnosed advanced ovarian cancer receiving neoadjuvant olaparib monotherapy vs. chemotherapy

Presenting Author: Karen Haney, MD , The University of Texas MD Anderson Cancer Center

Poster #51

Predictors of response to mirvetuximab soravtansine in ovarian cancer: A single-institution retrospective study

Presenting Author: Danielle Greenberg, University of California, Irvine

Poster #52

Ovarian cancer response to chemotherapy after use of PARPi

Presenting Author: Rachel Levy, MD , UCSF/KP

Poster #53

Actionable Biomarker Co-Expression in Advanced Ovarian Cancer: Folate Receptor alpha Expression and Related Markers

Presenting Author: Eliya Shachar, MD , University of California Los Angeles

Poster #54

Venous thromboembolism in recurrent ovarian cancer: associations with treatment burden, nutritional decline, and disease trajectory

Presenting Author: Caleigh Smith, MD , Cleveland Clinic

Poster #55

Communication preferences for patients

Presenting Author: Harriet Rothschild, MD , Department of Obstetrics, Gynecology and Reproductive Sciences

Poster #56

Quality of cancer care among Spanish speaking patients and families: perspectives on language access, relational care, community networks, and system gaps

Presenting Author: Larissa Aroche Gutierrez, MD, University of Washington

Poster #57

Teaching chemotherapy through comics for patients

Presenting Author: Alexandra Bartholomew, Student, Louisiana State University Health Sciences Center in New Orleans

Poster #58

Impact of a taxane titration protocol on incidence of hypersensitivity reactions in patients being treated for a gynecologic malignancy

Presenting Author: Harini Balakrishnan, MD , University of Oklahoma, Department of Obstetrics & Gynecology

Poster #59

Identifying and addressing inefficiencies during intraoperative frozen section in Gynecologic Oncology surgeries: a human factors approach

Presenting Author: Yingao Zhang, MD , Cedars-Sinai

Poster #60

Changes in Social Needs are Not Associated with Disease State Transitions among Cervical Cancer Patients at a Safety Net Hospital

Presenting Author: Eliya Shachar, MD , University of California Los Angeles

Poster #61

Use of decision tree analysis to prioritize rurality for intervention among geography-based barriers to outpatient specialty palliative care referrals for patients with gynecologic cancers.

Presenting Author: Hannah Nettelblad, University of Kansas

Poster #62

Barriers and facilitators to cervical cancer screening among American Indian/Alaska Native individuals aged 50-64 years

Presenting Author: Jessica Currier, Oregon Health & Science University, Knight Cancer Institutes

Poster #63

Primary HPV Screening Outcomes in a Large Safety-Net Health System

Presenting Author: Jo Kaur, UCLA

Poster #64

Primary HPV Screening Outcomes in a Large Safety-Net Health System

Presenting Author: Simone Sasse, MD , Stanford University

Poster #65

Characterizing and predicting instrumental activities of daily living impairment using a large language model in older adults with gynecologic cancer

Presenting Author: Stephanie Cham, MD, UCSF

Poster #66

Ocular Toxicity in Patients Receiving Antibody–Drug Conjugates for Gynecologic Malignancies in a high-altitude environment

Presenting Author: Stephanie Wang, MD , University of Colorado

Poster #67

Improving Treatment-Induced Menopause Counseling, Understanding, and Management among Gynecologic Oncology Patients: A Single Institution’s Experience

Presenting Author: Yifan Chang, MD , UCSF

Poster #68

Examining comprehensive treatment and survivorship needs in female cancer patients: A longitudinal pilot study

Presenting Author: Danielle Greenberg, MD, University of California, Irvine

Poster #69

Patterns and Timing of Palliative Care Referrals in Patients with Platinum-Resistant Ovarian Cancer

Presenting Author: Chinmayi Aryasomayajula, MD, University of California, Los Angeles

Poster #70

Navigating Uncertainty: Patient Experiences with Counseling in Recurrent Gynecologic Malignancy

Presenting Author: Tali Pomerantz, MD, UC Davis Health

Poster #71

Antibody–Drug Conjugates in Gynecologic Cancer Patients with Brain Metastases

Presenting Author: Eliya Shachar, MD , University of California Los Angeles

Poster #72

The Demographic and Genomic Landscape of Uterine Carcinosarcoma

Presenting Author: Ellery Koelker-Wolfe, MD, UCLA

Poster #73

Vulvar and vaginal cancer outcomes are not impacted by air quality

Presenting Author: Vishwa Shah, Loma Linda University Hospital

Poster #74

Vulvar Cancer in a Safety-Net Population: Stage and Survival in South Texas Bexar County Compared with National Cohorts

Presenting Author: Ashlyn Parkhurst, MD, University of Texas Health Science Center San Antonio

Poster #75

Outcomes and adverse events with immunotherapy use for patients with vulvovaginal melanoma

Presenting Author: Patrick Marta, MD, Harbor-UCLA Medical Center, Olive View-UCLA Medical Center

Poster #76

Talimogene Laherparepvec in advanced-stage vulvar and vaginal melanoma: a case report

Presenting Author: Gracie Williams, MD , Division of Gynecologic Oncology, Department of Surgery, City of Hope National Medical Center